Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy
- 1 November 2005
- journal article
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 40 (5) , 598-604
- https://doi.org/10.1016/s0008-4182(05)80052-3
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness (01792)
- National Institutes of Health (01792)
This publication has 25 references indexed in Scilit:
- Secondary Chronic Open-Angle Glaucoma After Intravitreal Triamcinolone AcetonideArchives of Ophthalmology (1950), 2003
- Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood–ocular barrier breakdownAlbrecht von Graefes Archiv für Ophthalmologie, 2002
- Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathyOphthalmology, 2001
- Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathyBritish Journal of Ophthalmology, 2000
- INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2000
- Intravitreal triamcinolone and elevated intraocular pressureAustralian and New Zealand Journal of Ophthalmology, 1999
- Vitrectomy With Silicone Oil or Long-Acting Gas in Eyes With Severe Proliferative Vitreoretinopathy: Results of Additional and Long-term Follow-upArchives of Ophthalmology (1950), 1997
- Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantationJournal of Cataract & Refractive Surgery, 1994
- Perisilicone Proliferation after Vitrectomy for Proliferative VitreoretinopathyOphthalmology, 1988
- Experimental and Clinical Observations of the Intraocular Toxicity of Commercial Corticosteroid PreparationsAmerican Journal of Ophthalmology, 1986